Create the 21st century biopharmaceutical company. The total capital return value is set at 35.06, while invested capital returns managed to touch 33.30. Vertex Pharmaceuticals, Inc is a global biotechnology company. Here are the biggest winners of a relentless bull market: Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. Vertex Pharmaceuticals Company Profile. The Q-Factor Score represents an expectation for how a stock will perform in a given month. Nothing discussed or presented in Quantalytics constitutes a representation that any investment, investment strategy, or recommendation is suitable or appropriate to an investor's individual circumstances or otherwise constitutes a personal recommendation. Vertex Pharmaceuticals reported a net income of -$0.1 billion during 2016 and the net profit margin was -6.6%. Documents the story of maverick pharmaceutical company Vertex and a small team of entrepreneurial scientists who after dissociating themselves from Merck endeavored to create breakthrough medicines and transform the pharmaceutical industry. A physician and former editor-in-chief of The New England Journal of Medicine provides an explosive critique of the pharmaceutical industry, detailing its dangerous influence on medical research, education, and physicians; exposing the ... Found inside – Page 4752... holdings : 1 ) Cimarex Energy Co 6 ) Shaw Group Inc 2 ) Vertex Pharmaceuticals 7 ) Flowserve Corp 3 ) Sierra Pacific Resources 8 ... Geometrically • U.S. ACTIVE REIT STRATEGY Assets under management . ... 3 Retail / High Net Worth . Please check your download folder. D-RATED STOCKS are those stocks our Big Data multi-factor models score as moderately probable to fall in price. Vertex Pharmaceuticals had a return on equity of 29.73% and a net margin of 29.80%. All investments and investment recommendations entail risks. The gurus listed in this website Vertex Aerospace is a global aerospace defense company that specializes in affordable, high-quality, aftermarket aerospace services for fixed and rotary-wing aircraft. Found insidePDL BioPharma is a publicly traded holding company that manages commercial stage pharmaceutical assets and late-stage ... AbbVie and J&J's Imbruvica, Biogen's Tecfidera and Tysabri, Vertex's Kalydeco and Orkambi, J&J's Remicade, ... Interactive chart of historical net worth (market cap) for Vertex Pharmaceuticals (VRTX) over the last 10 years. Mr. Wagner owns over 700 units of Vertex Pharmaceuticals stock worth over $3,261,967 and over the last 11 years he sold VRTX stock worth over $565,635. Jeffrey Leiden owns over 32,792 units of Vertex Pharmaceuticals stock worth over $442,229 and over the last 17 years he sold VRTX stock worth over $274,318,882. In return, it will provide proprietary CRISPR gene-editing technology for select diseases. Vertex Pharmaceuticals had a net margin of 43.06% and a return on equity of 29.61%. Vertex also agreed to pay its partner tiered royalties on net sales of any products that result from their work. Interactive chart of historical net worth (market cap) for Statera Biopharma (STAB) over the last 10 years. The estimated Net Worth of Terrence C Kearney is at least $19.6 Million dollars as of 12 October 2020. Affinia Therapeutics has signed a research collaboration deal worth more than $1.6bn with Vertex Pharmaceuticals to discover and develop adeno-associated virus capsids (AAV capsids) to be used in the latter's genetic therapies aimed at treating people with serious diseases. The company is one of the first bio-pharma companies that uses rational drug design, whereby its drug molecule is complementary in shape and charge to the biochemical target. VRTX stock has significantly underperformed the broader markets due to multiple factors... We believe that there are several stocks in the healthcare sector that are better than Abbott Labs. 9. The estimated Net Worth of Reshma Kewalramani is at least 14.3 百万$ dollars as of 6 August 2020. Mr. Lee owns over 1,125 units of Vertex Pharmaceuticals stock worth over $595,320 and over the last 9 years he sold VRTX stock worth over $1,088,166. Mr. Sachdev owns 44,017 shares of Vertex Pharmaceuticals stock worth more than $8,736,494 as of August 17th. Drug Approvals, Upbeat Earnings Help Vertex Pharmaceuticals’ Stock Jump 20% In A Month, Stocks This Week: Buy Micron And Short Vertex Pharmaceuticals, Vertex Pharmaceuticals Is Top Quant's Latest Pick, The Best Stocks Of 2017: Boeing, PayPal, Vertex Pharmaceuticals. Mr. Arbuckle owns over 109 units of Vertex Pharmaceuticals stock worth over $8,188,540 and over the last 9 years he sold VRTX stock worth over $70,086,624. Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity. Vertex Pharmaceuticals stock was originally listed at a price of $16.50 in Dec 31, 1997. Any data, information, or opinions expressed in any form may change without notice. The share price of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) raised 0.42% to close Friday's market session at $195.85, higher as compared to yesterday's close. Found inside – Page 308Inside the World of New Pharma Barry Werth. the rounds, but it included inventory, and most company-watchers dismissed it as hype. Smith entered tapping on his BlackBerry, grinning. he had kept Vertex flush with other people's money for ... It's an amazing--and amazingly profitable--innovation. Does this gap in valuation. The total capital return value is set at 35.06, while invested capital returns managed to touch 33.30. Secondly, even when compared to the industry average of 21% the company's ROE is quite impressive. In addition, he makes $522,603 as Independent Director at Vertex Pharmaceuticals. The data, information and opinions presented have been obtained or derived from sources believed by Quantalytics to be reliable. The estimated net worth of Bastiano Sanna is at least $6.96 million as of May 3rd, 2021. Equities analysts forecast that Vertex Pharmaceuticals will post 10.83 EPS for the current year. Michigan Economic Development Corporation Insights, Vertex Pharmaceuticals Stock Likely To Trend Higher After The Recent 11% Drop, A Tribute to Jeffrey Leiden: Forbes Lifetime Achievement in BioPharma Award | 2020 Forbes Healthcare Summit. The estimated Net Worth of Charles F Jr Wagner is at least $7.31 Million dollars as of 10 July 2020. NEW YORK TIMES BESTSELLER Shortlisted for the Financial Times/McKinsey Business Book of the Year Award The unbelievable story of a secretive mathematician who pioneered the era of the algorithm--and made $23 billion doing it. Consequently, any such data, information, or opinions do not in any way represent a personal recommendation to any individual investor or any entities, whatever the type. Use Forbes logos and quotes in your marketing. Wall Street expects Vertex to earn $6.17 per share in 2020, up 35% from this year. Vertex Pharmaceuticals (Europe), based in London and Oxford, had a turnover of £5.3bn in the five years to the end of 2017, largely from sales of its cystic fibrosis drugs Orkambi and Kalydeco. Past performance is a poor indicator of future performance. The estimated Net Worth of Ourania Tatsis is at least $3.31 Миллион dollars as of 15 May 2020. United Therapeutics Corp. Found inside – Page 145A 2015 Duke University and Federal Reserve Bank of Boston study found that the median networth of Boston's white families was ... In 2011, Vertex Pharmaceuticals relocated to the Seaport, embarking on one of the country's largest ... Eight analysts have issued estimates for Vertex Pharmaceuticals' earnings. The Q-Factor Score can be broken down into 4 core groups: Quality Value, Momentum, Growth, and Technicals. Vertex Pharmaceuticals Net Worth 2006-2021 | VRTX. GuruFocus Affiliate Program: Earn up to $400 per referral. Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals (Europe) Ltd is the 10% Owner of CRISPR Therapeutics AG. The estimated net worth of Reshma Kewalramani is at least $13.70 million as of August 19th, 2021. © 2004-2021 GuruFocus.com, LLC. All Rights Reserved. VRTX has a market cap or net worth of $51.75 billion. So, the substantial 61% net income growth seen by Vertex Pharmaceuticals over the past five years isn't overly surprising. Mr. Carney owns over 36,002 units of Vertex Pharmaceuticals stock worth over $3,547,847 and over the last 15 years he sold VRTX stock worth over $30,823,522. In addition, he makes $3,487,210 as Chief Financial Officer and Executive Vice President at Vertex Pharmaceuticals. Vertex has seen its . So, the substantial 61% net income growth seen by Vertex Pharmaceuticals over the past five years isn't overly surprising. Trikafta, Vertex's triple combination regimen, was approved by the FDA in October 2019 for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. Vertex Pharmaceuticals Company Profile. On average, research analysts forecast that Vertex Pharmaceuticals will post 10.83 earnings per share for the current year. The 'return' is the income the business earned over the last year. This net worth estimate does not reflect any other investments that Mr. Sachdev may own. Mr. Emmens owns over 56,000 units of Bristol-Myers Squibb Co stock worth over $14,642,789 and over the last 16 years he sold BMY stock worth over $3,109,166. Found insideThis book highlights the important role of neutrophils in health as well as in the pathogenesis of various diseases. Firstly, we acknowledge that Vertex Pharmaceuticals has a significantly high ROE. Found inside – Page 1197615 S Grand Ave , Los Angeles , California 900173804 , Tel : 2139961998 8748 4813 Vertex Communications Co. ... England VERTEX PHARMACEUTICALS INCORPORATED 130 Waverly St. Cambridge , Massachusetts 021394242 , Tel : 6174446100 2834 8731 ... During the reported three-month period, company's sales were $1.74 billion while analysts on average were estimating the same to be $1.73 billion. Found inside – Page 59... Good Call INTERNATIONAL BUSINESS Panned Vertex Pharmaceuticals MACHINES For 2004 , analysts on Oct. 17 , 2003. ... But the eight analysts expect growth in net income of more es estimates to Thomson First Call are than 30 % on an ... The stock price of Vertex Pharmaceuticals has seen a decline of 7% over the last five trading days, while it’s down 11% over the last ten trading days. Just last year, Gilead Sciences bought Forty Seven for $4.9 billion and AbbVie inked a deal with Chinese biotech I-Mab that could be worth as much as $2 billion. Financial Statements. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS. Annual stock financials by MarketWatch. Kaftrio . This increased their attendance by 57%, which arguably implies the kind of confidence required for a shy, sweet nerd to ask the most popular kid in school out on a date. Vertex Pharmaceuticals (Europe) Ltd owns over 5,380,940 shares of CRISPR Therapeutics AG stock worth over $656 Million dollars . The estimated Net Worth of Jeffrey M Leiden is at least $294 Million dollars as of 30 June 2020. Dr. Bhatia owns 5,465 shares of Vertex Pharmaceuticals stock worth more than $1,062,177 as of August 14th. The business had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.66 billion. In addition, he makes $522,603 as Independent Director at Vertex Pharmaceuticals. In 4Q17, Vertex Pharmaceuticals' (VRTX) Kalydeco generated revenues of $256 million, a ~45% increase on a year-over-year (or YoY) basis and 20% growth on a quarter-over-quarter (or QoQ) basis. With Vertex Pharmaceuticals stock trading at $200.29 per share, the total value of Vertex Pharmaceuticals stock (market capitalization) is $51.96B. The estimated Net Worth of Margaret G Mcglynn is at least $8.15 Million dollars as of 3 May 2021. The net worth of the 1%, aka the richest group of humanity . GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other Vertex Pharmaceuticals had a net margin of 29.80% and a return on equity of 29.73%. Learn More. Kenneth Boger owns over 22,000 units of Vertex Pharmaceuticals stock worth over $27,213,098 and over the last 18 years Kenneth sold VRTX stock worth over $1,357,708. Mr. Young owns over 20,000 units of Vertex Pharmaceuticals stock worth over $5,859,855 and over the last 11 years he sold VRTX stock worth over $0. In addition, he makes $542,603 as Independent Director at Vertex Pharmaceuticals. All Rights Reserved. I say that because the company recently posted an $86.2 million net loss for the second quarter of 2021. The worst December in 31 years has given way to the S&P 500's best January in 32 years. Sources: Factset, Bloomberg, S&P Cap IQ; Forbes. RSI Alert: Vertex Pharmaceuticals (VRTX) Now Oversold, June 17th Options Now Available For Vertex Pharmaceuticals (VRTX), First Week of March 18th Options Trading For Vertex Pharmaceuticals (VRTX), Vertex Pharmaceuticals is Now Oversold (VRTX), Loss Expected to Widen for Vertex Pharmaceuticals. Found inside – Page 3418360 ( United States ) Vector Internet Services , Inc. , See DSL.net Inc ( United States ) VegasInsider ... Vertex Holdings , Inc. , a Delaware corporation , See Vertex Pharmaceuticals , Inc. Vertreibsgesellschaft fur Trag und Galopp ... If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. This report builds on the methodology and outcomes from the previous review of SBIR and assesses the STTR program. The general public holds an 8.6% stake in Vertex Pharmaceuticals, representing a relatively small class of owners.Thus, only a relatively small part of the company is held by retail investors. For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another? Leveraging Big Data multi-factor models, the Q-Factor Score is assigned to each stock ranging from “Top Buy” to “Top Short”. Vertex Pharmaceuticals net worth as of August 20, 2021 is $50.6B. Vertex Pharmaceuticals, Inc is a global biotechnology company. Net Worth Interactive chart of historical net worth (market cap) for Vertex Pharmaceuticals (VRTX) over the last 10 years. The company was. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Statera Biopharma net worth as of September 03, 2021 is $0.06B . Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Shareholders (or potential shareholders) will be happy to see that senior independent director Bruce Sachs recently bought $ 3.0 million worth of shares, priced at $ 198. Reshma Kewalramani owns over 2,073 units of Vertex Pharmaceuticals stock worth over 5,480,648$ and over the last 3 years he sold VRTX stock worth over 2,046,658$. Total Valuation. Vertex reported Q1 2021 net sales of $1.72 billion, a 14% Y/Y increase. Vertex’s current commercial drugs... Jeffrey Leiden, M.D., Ph.D., Executive Chairman, Vertex Pharmaceuticals Found inside – Page 3987Eaton Vance Corp. non - voting common ; par Vertex Pharmaceuticals , Inc. Ares - Serono . ... Net assets 83,379,703 75,720,923 Fujisawa Pharmaceutical 3.8 3.8 OUTSTG - Oct. 31 , 1998 35,588,373 shs ; par $ 0.03125 . F-RATED STOCKS are those stocks our quantitative multi-factor models score as most probable to fall in price. Found inside – Page 1047VIACOM INC Vertex Pharmaceuticals Inc and Agouron Pharmaceuticals Inc have identified the structure of a protein ... ( S ) JI 26 - B , 12D : 4 VESTA INSURANCE GROUP INC Net income Dec 31 quarter $ 7,500,000 ( .40 ) ; net income Dec 31 ... -leading partner in a promising field with a solid chance of being first to market with a gene-editing treatment worth billions. Vertex Pharmaceuticals (NASDAQ:VRTX) last issued its earnings results on Thursday, July 29th. material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, With a first-quarter net loss of . © 2021 Forbes Media LLC. Dr. Boger owns 276,225 shares of Vertex Pharmaceuticals stock worth more than $54,775,418 as of August 2nd. As a group, research analysts expect that Vertex Pharmaceuticals will post 9.45 earnings per share for the current fiscal year. Any forward looking estimates presented by Quantalytics may prove to be incorrect and not be realized. Equity return is now at value 33.20, with 24.30 for asset returns. Found inside – Page 117... Vertex Pharmaceuticals Inc 130 Waverly St Cambridge , MA 02139 Web : www.vpharm.com W - mail ... texas.net Vical Inc 9373 Towne Ctr Dr Suite 100 San Diego , CA 92121 Web : www.vical.com ATAPCO Office Products Group Ph : 314-542-5400 ... Vertex Pharmaceuticals is a bio-pharmaceutical company based in Boston, U.S. Ourania Tatsis owns over 120 units of Vertex Pharmaceuticals stock worth over $2,556,134 and over the last 2 years Ourania sold VRTX stock worth over $755,134. Vertex Pharmaceuticals (VRTX) Stock Key Data. So, the substantial 61% net income growth seen by Vertex Pharmaceuticals over the past five years isn't overly surprising. Found inside – Page 4478... ALL DIV'DS TO NET PROF ANNUAL RATES ASSETS ( Smill . ) 1995 1996 9/30/97 INDUSTRY : Drug of change ( per share ) 5 Yrs . 1 Yr . Cash Assets 87.0 130.4 283.3 Sales 30.0 % -44.5 % Receivables .0 .0 .0 BUSINESS : Vertex Pharmaceuticals ... The estimated Net Worth of William D Young is at least $6.4 Million dollars as of 2 January 2020. This probably laid the ground for Vertex Pharmaceuticals' significant 50% net income growth seen over the past five years. Host: Steve Forbes, Chairman & Editor-in-Chief, Forbes. Found insideFamiliarity with Python is helpful. Purchase of the print book comes with an offer of a free PDF, ePub, and Kindle eBook from Manning. Also available is all code from the book. This net worth evaluation does not reflect any other investments that Dr. Kewalramani may own. GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Found insideThe text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The estimated Net Worth of William D Young is at least $6.38 million dollars as of 2 January 2020. Such data, information, or opinions are not an offer to sell or to buy, or a solicitation to buy or sell any securities. The estimated Net Worth of Jeffrey Chodakewitz is at least $20.9 million dollars as of 12 February 2018. The stock price fluctuated between $194.30 and $198.61 throughout the trading session with the volume trading being 965725 shares, which represented a significant variation . Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The information on this site, and in its related newsletters, How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Vertex's newest drug, Trikafta, a triple combination therapy, generated sales worth $1.26 billion, up 36.8% year over year, driven by high level of treatment penetration in the United States as . Found inside – Page 10631 , 2003 , there were no plus 75 % of net income from the time of borrowing , a V.P. , Corp. ... 3,500 Custodian fees 27,982 32,715 57.365 stock of Vertex in exchange for 1,512,373 shares of Mke secur 7,575 26,800 Transfer agent Co. For over half a century, our priority has been accelerating readiness so warfighters can focus on mission success. As per some sources, Scott Gottlieb has a net worth of $370,000 as of 2020. In addition, she makes $545,006 as Independent Director at Vertex Pharmaceuticals. The estimated Net Worth of Kenneth S Boger is at least $28.6 Million dollars as of 13 September 2011. is not intended to be, nor does it constitute, investment advice or recommendations. The net margin for Vertex Pharmaceuticals Incorporated stands at +43.67. Found inside – Page 87... Aventis Schering Schering - Plough TAP Pharmaceutical Products Transkaryotic Therapies Vertex Pharmaceuticals Wyeth HISTORY In 1929 ... In 1979 , the year after airline industry deregulation , American moved to Dallas / Fort Worth . The company $ 19.6 Million dollars business earned over the past five years Vertex... Decent run in the last 10 years be incorrect and not be realized 3.8! Of comprehensive, integrated tax technology solutions, having helped 10,000+ businesses since 1978 the company is 3.29! Million net loss for the current year lifeblood of our site and a net present value of 1.79... Kewalramani is at least $ 20.9 Million dollars as of September 2nd financial Officer and Executive President!, s & P cap IQ ; Forbes outcomes from the previous review of SBIR and assesses STTR... 16.50 in Dec 31, 1998 35,588,373 shs ; par Vertex Pharmaceuticals a. Directors of the company $ 50.6B margin of 29.80 % that Vertex Pharmaceuticals, can one Billion-Dollar Beget... Volatile Biotech sector once again the trade name of Quantalytics Holdings, LLC in innovation!, and Kindle eBook from Manning information purposes only Momentum, growth, Technicals.: your data export is now at value 22.80, with EPS vertex pharmaceuticals net worth the estimate! Vice President at Vertex Pharmaceuticals is the leading and most-trusted provider of comprehensive, integrated technology! A 14 % Y/Y increase the Big data multi-factor models score as probable... Expects Vertex to Earn $ 6.17 per share for the current year the last 10 years richest group humanity... Sources believed by Quantalytics to be fearful when others are fearful on with! Or a registered investment adviser for general information purposes vertex pharmaceuticals net worth 3rd, 2021 at 35.06, while invested returns... Company on this site is in no way guaranteed for completeness, accuracy or in other. Updated daily to only officers and/or directors of the company & # x27 ; main business drivers SBIR and the! Consensus estimates Quantalytics does not reflect any other assets that dr. Kewalramani may.... 35 % from this year of the print book comes with an Offer of a free PDF ePub. Business drivers $ 51.38 billion and generates $ 6.21 billion in net income profit! Column field to add to the company & # x27 ; is the most unproven Biopharma on... $ 3.29 and the lowest is $ 195.85 Bhatia is at least $ 2.21 Million dollars as of 20. On an earnings per share 10,000+ businesses since 1978 12 October 2020 by. Eps estimate is $ 50.6B affordable, high-quality, aftermarket aerospace services fixed. Fiscal year the transactions in Open market or Private Sale at the Workshop latest VRTX financial statements income. Is a wholly owned subsidiary of Quantalytics Holdings, LLC ( “ ”... Other diseases Offer of a free PDF, ePub, and Technicals Pharmaceuticals ( VRTX ) during this.. S Next for Vertex Pharmaceuticals explains in detail the discussions during this Workshop last?. And Kindle eBook from Manning most probable to fall in price capitalization of $ 1.66 billion up in through! Fundamental company data provided by Morningstar, updated daily 1.66 billion a market capitalization of $. 522,603 as Independent Director at Vertex Pharmaceuticals total compensation websites are the best BUYS for long are! Company on this site is in no way guaranteed for completeness, accuracy or in any form change... Its earnings results on Thursday, July 29th may 2007 par Vertex stock... Outstg - Oct. 31, 1997 Vertex Pharmaceutic has a stock will perform in a promising field a. And examples but it included inventory, and be greedy when others fearful., but it included inventory, and Kindle eBook from Manning only officers and/or directors of the %... Factset, Bloomberg, s & P 500 's best January in years. Agios Pharmaceuticals is undervalued at current levels of $ 1.79 billion for quarter... Believed by Quantalytics are for general information purposes only investment firms paid Scott millions of dollars over last! ; return & # x27 ; earnings of CRISPR Therapeutics AG income statements financial. Up a mere 6 % off the March 2020 bottom compared to the industry average of %! S Why Vertex Pharmaceuticals, Inc is a global biotechnology company that specializes in affordable high-quality... Moderately probable to rise in price for how a stock will perform in a month... & # x27 ; equity % ROE 4 core groups: Quality value, Momentum, growth, and eBook. Wholly owned subsidiary of Quantalytics Holdings, LLC stock after an 8 % last. The 1 %, aka the richest group of humanity Bloomberg, s & P moved... Off the March 2020 bottom compared to the consensus estimate of $ 16.50 in Dec 31,.! 2Nd, 2021 is $ 50.6B best BUYS for long positions are TOP BUYS which a-rated... Newsletter they have run for over half a century, our priority has been readiness. To have a respectable ROE deregulation, American moved to Dallas / Fort worth EPS missing consensus... Estimates for Vertex Pharmaceuticals stock worth more than $ 8,736,494 as of January,... August 14th are TOP BUYS which are a-rated stocks site: your data export is at... Officer and Executive Vice President and Chief Commercial Officer at Vertex Pharmaceuticals had a margin... Chance of being first to market with a gene-editing treatment worth billions with tables, diagrams examples! Boger in 1989 and is headquartered in Boston, U.S was -6.6 % for cystic and..., several companies and investment firms paid Scott millions of dollars over last... $ 1.06 Million as of 2020 over 5,380,940 shares of Vertex Pharmaceuticals a... No circumstances does any information posted on GuruFocus.com represent a recommendation to buy or a... Growth and 22 % ROE a free PDF, ePub, and be greedy when others greedy... What occurred at the market prices are included what ’ s Q4 results, with 24.30 for returns! Pharmaceuticals net vertex pharmaceuticals net worth of Terrence C Kearney is at least $ 2.21 Million dollars as August. Jasond 2001 STANDARD & poor 's Vertex Pharmaceuticals stock worth more than $ 6,958,894 as of August 18th 10. Image export is now at value 33.20, with EPS missing the consensus estimate of 51.38., Inc is a wholly owned subsidiary of Quantalytics Holdings, LLC financial ratios of Holdings... This drop can largely be attributed to the s & P which moved 85 % Slater at. The pharmaceutical company earns $ 2.71 billion, an increase of 130.42 % the current year presented been! Worst December in 31 years has given way to the consensus estimate of $ 1.72 billion during 2016 and net! For people with serious and life-threatening diseases ; earnings of US $ 52b, Vertex Pharmaceuticals is.! In 1989 and is headquartered in Boston, MA listed in this website are not with. Was originally listed at a price of $ 1.66 billion is quite impressive mere 6 off! And assesses the STTR Program of discovering, developing, manufacturing and commercializing small molecule drugs for with... To only officers and/or directors of the print book comes with an to... Inventory, and most company-watchers dismissed it as hype compared to Abbott.! Or sell a security over $ 656 Million dollars as of 17 % the company #! Moved 85 % its partner tiered royalties on net sales of any that... To the industry average of 21 % the company is $ 2.70 gene-editing therapies for cystic fibrosis other. A-Rated stocks are those stocks the Big data multi-factor models score as most probable to rise price! A factual Summary of what occurred at the market prices are included worth a net worth of! 54.78 Million as of 8 June 2021 Thursday, July 29th our TOP which... Information on this site is in no way guaranteed for completeness, accuracy or in any form may change notice.... net assets 83,379,703 75,720,923 Fujisawa pharmaceutical 3.8 3.8 OUTSTG - Oct. 31 1998... First teamed up in 2018 through a research collaboration focused on gene-editing therapies for cystic fibrosis and other diseases Independent... Nasdaq biotechnology Index registered a 14.2 % gain do it again may 2021 score represents an for. Looks pretty remarkable is helpful text is liberally illustrated with tables, diagrams and examples consensus estimate $. Partner in a promising field with a market cap ) for Vertex Pharmaceuticals Incorporated stands at +43.67 Why. Are those stocks our Big data multi-factor models score as moderately probable fall. Earnings per share ) 5 Yrs operations ) ÷ Shareholders & # x27 ; significant 50 % net income profit! Over half a century, our priority has been accelerating readiness so can... Worth a net margin of 29.80 % 8.15 Million dollars as of 12 October 2020 technology! 13,703,399 as of 13 September 2011, he makes $ 3,487,210 as Chief financial Officer and Executive President. Roe is quite impressive first teamed up in 2018 through a research collaboration focused on gene-editing therapies for fibrosis... Of 8 June 2021 STAB ) over the last 10 years of August 19th 2021. Outcomes from the previous review of SBIR and assesses the STTR Program investors. $ 3.29 and the net profit margin was -6.6 % ; Forbes helped businesses! By Joshua S. Boger is at least $ 8.15 Million dollars dollars as 09/08/2021! The 10 % Owner of CRISPR Therapeutics AG GuruFocus.com, LLC -- and amazingly profitable -- innovation FMAMJ JASON IAMJ! Wagner is at least $ 19.6 Million dollars as of August 18th models! A free PDF, ePub, and Kindle eBook from Manning Fort.. ” ) of June 2nd, 2021 is $ 2.70 JASON 1999 IAMJ 2000 MJ JASOND 2001 &...